These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 11121477)

  • 1. A novel four zinc-finger protein targeted against p190(BcrAbl) fusion oncogene cDNA: utilisation of zinc-finger recognition codes.
    McNamara AR; Ford KG
    Nucleic Acids Res; 2000 Dec; 28(24):4865-72. PubMed ID: 11121477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Philadelphia chromosome-positive leukaemia: the translocated genes and their gene products.
    Allen PB; Morgan GJ; Wiedemann LM
    Baillieres Clin Haematol; 1992 Oct; 5(4):897-930. PubMed ID: 1308169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BCR sequences essential for transformation by the BCR-ABL oncogene bind to the ABL SH2 regulatory domain in a non-phosphotyrosine-dependent manner.
    Pendergast AM; Muller AJ; Havlik MH; Maru Y; Witte ON
    Cell; 1991 Jul; 66(1):161-71. PubMed ID: 1712671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleotide sequence analysis of human abl and bcr-abl cDNAs.
    Fainstein E; Einat M; Gokkel E; Marcelle C; Croce CM; Gale RP; Canaani E
    Oncogene; 1989 Dec; 4(12):1477-81. PubMed ID: 2687768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of the three-dimensional distribution of abl and bcr genes in the formation of bcr/abl fusion gene in interphase neucleus].
    Zhang Q; Zhou SY; Liu XL; Niu C; Xu L; Chen SJ
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Mar; 22(3):197-9. PubMed ID: 12390759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The bcr-abl gene in chronic myelogenous leukaemia.
    Sawyers CL
    Cancer Surv; 1992; 15():37-51. PubMed ID: 1451113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the BCR-ABL oncogene in human leukemia: fifteenth Richard and Hinda Rosenthal Foundation Award Lecture.
    Witte ON
    Cancer Res; 1993 Feb; 53(3):485-9. PubMed ID: 8425181
    [No Abstract]   [Full Text] [Related]  

  • 8. TLS/FUS, a pro-oncogene involved in multiple chromosomal translocations, is a novel regulator of BCR/ABL-mediated leukemogenesis.
    Perrotti D; Bonatti S; Trotta R; Martinez R; Skorski T; Salomoni P; Grassilli E; Lozzo RV; Cooper DR; Calabretta B
    EMBO J; 1998 Aug; 17(15):4442-55. PubMed ID: 9687511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo repression by a site-specific DNA-binding protein designed against an oncogenic sequence.
    Choo Y; Sánchez-García I; Klug A
    Nature; 1994 Dec; 372(6507):642-5. PubMed ID: 7990954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Bcr N-terminal oligomerization domain contributes to the full oncogenicity of P190 Bcr/Abl in transgenic mice.
    Heisterkamp N; Voncken JW; Senadheera D; Hemmeryckx B; Gonzalez-Gomez I; Reichert A; Pattengale PK; Groffen J
    Int J Mol Med; 2001 Apr; 7(4):351-7. PubMed ID: 11254872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel variant of the bcr-abl fusion product in Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Soekarman D; van Denderen J; Hoefsloot L; Moret M; Meeuwsen T; van Baal J; Hagemeijer A; Grosveld G
    Leukemia; 1990 Jun; 4(6):397-403. PubMed ID: 2193202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a protein that binds to the SH3 region of Abl and is similar to Bcr and GAP-rho.
    Cicchetti P; Mayer BJ; Thiel G; Baltimore D
    Science; 1992 Aug; 257(5071):803-6. PubMed ID: 1379745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of tyrosinase kinase and microfilament-binding functions of c-abl by bcr sequences in bcr/abl fusion proteins.
    McWhirter JR; Wang JY
    Mol Cell Biol; 1991 Mar; 11(3):1553-65. PubMed ID: 1705008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ribozyme-mediated inhibition of a Philadelphia chromosome-positive acute lymphoblastic leukemia cell line expressing the p190 bcr-abl oncogene.
    Snyder DS; Wu Y; McMahon R; Yu L; Rossi JJ; Forman SJ
    Biol Blood Marrow Transplant; 1997 Oct; 3(4):179-86. PubMed ID: 9360779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein.
    Pendergast AM; Quilliam LA; Cripe LD; Bassing CH; Dai Z; Li N; Batzer A; Rabun KM; Der CJ; Schlessinger J
    Cell; 1993 Oct; 75(1):175-85. PubMed ID: 8402896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved specificity of ribozyme-mediated cleavage of bcr-abl mRNA.
    Kearney P; Wright LA; Milliken S; Biggs JC
    Exp Hematol; 1995 Aug; 23(9):986-9. PubMed ID: 7543419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KBM-7, a human myeloid leukemia cell line with double Philadelphia chromosomes lacking normal c-ABL and BCR transcripts.
    Andersson BS; Collins VP; Kurzrock R; Larkin DW; Childs C; Ost A; Cork A; Trujillo JM; Freireich EJ; Siciliano MJ
    Leukemia; 1995 Dec; 9(12):2100-8. PubMed ID: 8609723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo inhibition by a site-specific catalytic RNA subunit of RNase P designed against the BCR-ABL oncogenic products: a novel approach for cancer treatment.
    Cobaleda C; Sánchez-García I
    Blood; 2000 Feb; 95(3):731-7. PubMed ID: 10648380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of the Bcr-Abl oncoprotein by Bcr requires phosphoserine 354.
    Hawk N; Sun T; Xie S; Wang Y; Wu Y; Liu J; Arlinghaus RB
    Cancer Res; 2002 Jan; 62(2):386-90. PubMed ID: 11809685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exon-skipping in BCR/ABL is induced by ABL exon 2.
    Lichty BD; Kamel-Reid S
    Biochem J; 2000 May; 348 Pt 1(Pt 1):63-9. PubMed ID: 10794714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.